{
  "retracted": false,
  "timestamp": 1560211200000,
  "updates": [
    {
      "timestamp": 1574262612315,
      "identifier": {
        "doi": "10.1182/bloodadvances.2019000319"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/bloodadvances.2018030411"
  },
  "journal": "Blood Advances",
  "publisher": "American Society of Hematology",
  "title": "Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983."
}
